[
  {
    "ts": null,
    "headline": "Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?",
    "summary": "Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=74df5cb629666184a44afe0971eaf4ede2b73476a7d1428b0f2c603ee1be93e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753880404,
      "headline": "Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?",
      "id": 136149083,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=74df5cb629666184a44afe0971eaf4ede2b73476a7d1428b0f2c603ee1be93e2"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Value Fund Q2 2025  Commentary",
    "summary": "Franklin Templeton reviews Q2 for ClearBridge Value Fund, highlighting AI-driven power picks and inflation hedges. Explore where they see opportunity next.",
    "url": "https://finnhub.io/api/news?id=b460b6ffacf228e5e2c51999d77430162c4da7479cafbc71b076706696b35c67",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753872900,
      "headline": "ClearBridge Value Fund Q2 2025  Commentary",
      "id": 136131852,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2178163747/image_2178163747.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Franklin Templeton reviews Q2 for ClearBridge Value Fund, highlighting AI-driven power picks and inflation hedges. Explore where they see opportunity next.",
      "url": "https://finnhub.io/api/news?id=b460b6ffacf228e5e2c51999d77430162c4da7479cafbc71b076706696b35c67"
    }
  },
  {
    "ts": null,
    "headline": "Infectious Disease Treatment Market Report 2025-2030 | Long-acting Injectables, Self-testing Kits, and Combination Therapies Fueling Growth",
    "summary": "The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with a CAGR of 6.9%. Driven by ongoing health challenges, emerging trends include long-acting injectables, self-testing kits, and combination therapies. Key players include Gilead Sciences, Sanofi, and Merck. Infectious Disease Treatments Market Infectious Disease Treatments Market Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The \"Global Markets for Infectious Disease Treatments\"",
    "url": "https://finnhub.io/api/news?id=39425dd56c72d8a96acfc44ac6bd529fbf25e19bdaeb862305635d78cbbe6669",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753872780,
      "headline": "Infectious Disease Treatment Market Report 2025-2030 | Long-acting Injectables, Self-testing Kits, and Combination Therapies Fueling Growth",
      "id": 136129850,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with a CAGR of 6.9%. Driven by ongoing health challenges, emerging trends include long-acting injectables, self-testing kits, and combination therapies. Key players include Gilead Sciences, Sanofi, and Merck. Infectious Disease Treatments Market Infectious Disease Treatments Market Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The \"Global Markets for Infectious Disease Treatments\"",
      "url": "https://finnhub.io/api/news?id=39425dd56c72d8a96acfc44ac6bd529fbf25e19bdaeb862305635d78cbbe6669"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL",
    "summary": "Jaypirca met its non-inferiority primary endpoint, trumping Imbruvica in patient overall response rate (ORR).",
    "url": "https://finnhub.io/api/news?id=012aa4ed868c1c7e047e64764fd3f20c7b42cabe04677cda546a6c7eb053b1bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753868462,
      "headline": "Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL",
      "id": 136129640,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Jaypirca met its non-inferiority primary endpoint, trumping Imbruvica in patient overall response rate (ORR).",
      "url": "https://finnhub.io/api/news?id=012aa4ed868c1c7e047e64764fd3f20c7b42cabe04677cda546a6c7eb053b1bb"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Lenacapavir Injection Market Size/Share Worth USD 5.68 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Lenacapavir Injection Market size & share revenue was valued at approximately USD 3.5 Billion in 2024 and is expected to reach USD 3.66 Billion in 2025 and is expected to reach around USD 5.68 Billion by 2034, at a CAGR of 5.1% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Gilead Sciences, Dr. Reddy’s",
    "url": "https://finnhub.io/api/news?id=f63c6944462f30737ec8b786376be44a7ada2fbca06ee2972a78d9db196ebed8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753864200,
      "headline": "[Latest] Global Lenacapavir Injection Market Size/Share Worth USD 5.68 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136129715,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Lenacapavir Injection Market size & share revenue was valued at approximately USD 3.5 Billion in 2024 and is expected to reach USD 3.66 Billion in 2025 and is expected to reach around USD 5.68 Billion by 2034, at a CAGR of 5.1% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Gilead Sciences, Dr. Reddy’s",
      "url": "https://finnhub.io/api/news?id=f63c6944462f30737ec8b786376be44a7ada2fbca06ee2972a78d9db196ebed8"
    }
  },
  {
    "ts": null,
    "headline": "Earn A Potential 12%-14% Consistent Income: Monthly Options Series (August 2025)",
    "summary": "Earn A Potential 12%-14% Consistent Income: Monthly Options Series (August 2025)",
    "url": "https://finnhub.io/api/news?id=ac0bbfa102e0e2cd8a6da22bc7b65d29a7f05e76ceeb8aa01c4d215105b87530",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753862460,
      "headline": "Earn A Potential 12%-14% Consistent Income: Monthly Options Series (August 2025)",
      "id": 136129017,
      "image": "",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=ac0bbfa102e0e2cd8a6da22bc7b65d29a7f05e76ceeb8aa01c4d215105b87530"
    }
  }
]